Nalaganje...

Consequence of Dose Scheduling of Sunitinib on Host Immune Response Elements and Vaccine Combination Therapy

This study investigated the immunomodulatory effects of sunitinib in order to rationally design combinational platforms with immunotherapies for the treatment of solid tumors. Using a mouse model, we studied the effects of sunitinib given for 4 weeks at concentrations comparable to 37.5–50 mg/day in...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Farsaci, Benedetto, Higgins, Jack P., Hodge, James W.
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3232304/
https://ncbi.nlm.nih.gov/pubmed/21633954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.26219
Oznake: Označite
Brez oznak, prvi označite!